Viral therapies for glioblastoma and high-grade gliomas in adults: a systematic review

20Citations
Citations of this article
51Readers
Mendeley users who have this article in their library.

Abstract

OBJECTIVE High-grade gliomas (HGGs) inevitably recur and progress despite resection and standard chemotherapies and radiation. Viral therapies have emerged as a theoretically favorable adjuvant modality that might overcome intrinsic factors of HGGs that confer treatment resistance.

Cite

CITATION STYLE

APA

Wang, J. L., Scheitler, K. M., Wenger, N. M., & Elder, J. B. (2021). Viral therapies for glioblastoma and high-grade gliomas in adults: a systematic review. Neurosurgical Focus, 50(2), 1–14. https://doi.org/10.3171/2020.11.FOCUS20854

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free